Biochips Market Size, Share | Trends Report 2023-28
IMARC Group, a leading market research company, has recently releases report titled “Biochips Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” The study provides a detailed analysis of the industry, including the global biochips market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Report Highlights
How big is the biochips market?
The global biochips market size reached US$ 16.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 40.6 Billion by 2028, exhibiting a growth rate (CAGR) of 15.8% during 2023-2028.
What are biochips?
Biochips are miniature versions of a laboratory designed for functioning in a biological environment, especially inside living organisms. They contain millions of sensor elements or biosensors that act as microreactors to detect a particular analyte like a protein, DNA, enzyme, or antibody. They can perform thousands of biological reactions in a few seconds for drug discovery, single nucleotide polymorphism genotyping, in-vitro diagnostics, gene expression profiling and agricultural biotechnology.
Request for a sample copy of this report: https://www.imarcgroup.com/biochips-market/requestsample
What are the growth prospects and trends in the biochips industry?
The global biochips market is primarily driven by growing investments in the healthcare sector. The onset of the coronavirus disease (COVID-19) pandemic has encouraged several biotechnology and pharmaceutical companies to develop biochips for detecting viral infections and immunological disorders in the human body. Besides this, these chips are widely used in the medical industry to detect cancerous cells in the body and for forming targeted and personalized medicines for cancer treatment. Moreover, several advancements and upgradation in nanotechnology and extensive research and development (RD) activities that results in the emergence of digital microfluidic biochips are also providing a positive thrust to the market growth.
What is included in market segmentation?
The report has segmented the market into the following categories:
Breakup by Product Type:
DNA Chip
Protein Chip
Lab-On-a-Chip
Enzyme Chip
Breakup by Fabrication Technique:
Microarray
Microfluidic
Breakup by Analysis Method:
Electrophoresis
Luminescence
Mass Spectrometry
Electrical Signals
Magnetism
Breakup by Application:
Molecular Analysis
Hybridization
Protein
Immunological
Biomolecules
Biomarker
Others
Diagnosis
Gene Diagnosis
Oncology
Inflammatory
Others
Non-Biological Usage
Breakup by End User:
Pharmaceutical and Biotechnology Companies
Hospitals and Diagnostics Centers
Academic Research Institutes
Others
Breakup by Region:
North America (U.S. Canada)
Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
Latin America (Brazil, Mexico)
Middle East Africa
Who are the key players operating in the industry?
The report covers the major market players including:
Agilent Technologies, Inc.
bioMérieux SA
Bio-RAD Laboratories, Inc.
CapitalBio Corporation
Dynamic Biosensors GmbH
EMD Millipore Corporation
Fluidigm Corporation
Illumina, Inc.
Perkinelmer, Inc.
Thermo Fisher Scientific Inc
Ask Analyst for Customization and Browse full report with TOC List of Figure: https://www.imarcgroup.com/request?type=report&id=2741&flag=C
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/